Prometheus Biosciences, Inc.
RXDXDelisted Jun 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001718852
Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.
Holders of 5% or more of RXDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Prometheus Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Prometheus Biosciences, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Prometheus Biosciences, Inc., newest first.
No Schedule 13D or 13G filings on Prometheus Biosciences, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Prometheus Biosciences, Inc. shares.
No Form 144 notices for Prometheus Biosciences, Inc. are on file.